Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Genasys (GNSS) over the last 16 years, with Q4 2025 value amounting to $10.3 million.

  • Genasys' Cash & Equivalents rose 2145.47% to $10.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.3 million, marking a year-over-year increase of 2145.47%. This contributed to the annual value of $8.0 million for FY2025, which is 6115.27% up from last year.
  • According to the latest figures from Q4 2025, Genasys' Cash & Equivalents is $10.3 million, which was up 2145.47% from $8.0 million recorded in Q3 2025.
  • In the past 5 years, Genasys' Cash & Equivalents ranged from a high of $18.5 million in Q1 2021 and a low of $3.0 million during Q2 2023
  • Moreover, its 5-year median value for Cash & Equivalents was $8.6 million (2023), whereas its average is $8.7 million.
  • In the last 5 years, Genasys' Cash & Equivalents plummeted by 7465.67% in 2023 and then skyrocketed by 19188.83% in 2024.
  • Quarter analysis of 5 years shows Genasys' Cash & Equivalents stood at $10.1 million in 2021, then dropped by 25.38% to $7.6 million in 2022, then tumbled by 36.8% to $4.8 million in 2023, then surged by 77.18% to $8.5 million in 2024, then rose by 21.45% to $10.3 million in 2025.
  • Its Cash & Equivalents stands at $10.3 million for Q4 2025, versus $8.0 million for Q3 2025 and $5.3 million for Q2 2025.